Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Albanell

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Seminars in Oncology|June 23, 2000
Systemic therapy emergenciesJ Albanell, J Baselga
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Mechanism of action of anti-HER2 monoclonal antibodiesJ Baselga, J Albanell
Drugs of Today (Barcelona, Spain : 1998)|September 16, 2003
Trastuzumab, a humanized anti-HER2 monoclonal antibody, for the treatment of breast cancerJ Albanell, J Baselga
Journal of the National Cancer Institute|December 26, 2001
Unraveling resistance to trastuzumab (Herceptin): insulin-like growth factor-I receptor, a new suspectJ Albanell, J Baselga
Journal of Mammary Gland Biology and Neoplasia|March 8, 2000
The ErbB receptors as targets for breast cancer therapyJ Albanell, J Baselga
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 13, 2009
Predictive modelling in hormone-refractory prostate cancer (HRPC)J Bellmunt, J Carles, J Albanell
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 9, 2006
The proteasome: a novel target for anticancer therapyC Montagut, A Rovira, J Albanell
Seminars in Oncology|November 14, 2001
Pharmacodynamic studies with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839J Albanell, F Rojo, J Baselga
Critical Reviews in Oncology/Hematology|August 30, 2008
Prostate cancer. Multidisciplinary approach: a key to successC Montagut, J Albanell, J Bellmunt
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1991
Nail-fold capillary microscopy and chemotherapy-induced vascular toxicityJ Bellmunt, S Morales, J Albanell, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Seminars in Oncology|June 23, 2000
Systemic therapy emergenciesJ Albanell, J Baselga
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Mechanism of action of anti-HER2 monoclonal antibodiesJ Baselga, J Albanell
Drugs of Today (Barcelona, Spain : 1998)|September 16, 2003
Trastuzumab, a humanized anti-HER2 monoclonal antibody, for the treatment of breast cancerJ Albanell, J Baselga
Journal of the National Cancer Institute|December 26, 2001
Unraveling resistance to trastuzumab (Herceptin): insulin-like growth factor-I receptor, a new suspectJ Albanell, J Baselga
Journal of Mammary Gland Biology and Neoplasia|March 8, 2000
The ErbB receptors as targets for breast cancer therapyJ Albanell, J Baselga
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 13, 2009
Predictive modelling in hormone-refractory prostate cancer (HRPC)J Bellmunt, J Carles, J Albanell
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 9, 2006
The proteasome: a novel target for anticancer therapyC Montagut, A Rovira, J Albanell
Seminars in Oncology|November 14, 2001
Pharmacodynamic studies with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839J Albanell, F Rojo, J Baselga
Critical Reviews in Oncology/Hematology|August 30, 2008
Prostate cancer. Multidisciplinary approach: a key to successC Montagut, J Albanell, J Bellmunt
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1991
Nail-fold capillary microscopy and chemotherapy-induced vascular toxicityJ Bellmunt, S Morales, J Albanell, et al.
Pageof 10